Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intas Pharmaceuticals is a leading global pharmaceutical company headquartered in Ahmedabad, India, with a significant presence in the chronic therapeutic segments. The company is the manufacturer of Vyfat, a widely used brand of the anti-obesity medication orlistat, which functions as a lipase inhibitor to reduce dietary fat absorption. Intas operates extensive manufacturing facilities and R&D centers, focusing on a diverse portfolio that includes formulations, biologics, and specialty medicines. With a commercial footprint in over 85 countries, the company is recognized for its robust pipeline and leadership in the Indian pharmaceutical market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vyfat.